Fengzhen Mo
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 13
- Oncology 11
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Xiaoling Lü (21 shared papers)Xiaoqiong Hou (15 shared papers)Zhuoran Tang (10 shared papers)Xiaomei Yang (16 shared papers)Aiqun Liu (14 shared papers)Siliang Duan (8 shared papers)Shihua Yin (8 shared papers)Zixi Hu (6 shared papers)
- Journals
- Journal of Biomedical Nanotechnology (5 papers)Theranostics (4 papers)International Journal of Nanomedicine (3 papers)Journal of Nanoscience and Nanotechnology (2 papers)Oncology Reports (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fengzhen Mo
21 papers receiving 489 citations
Peers
Comparison fields: 5 of 56
- Immunology 223
- Oncology 228
- Radiology, Nuclear Medicine and Imaging 116
- Biomaterials 50
- Molecular Biology 217
Countries citing papers authored by Fengzhen Mo
This map shows the geographic impact of Fengzhen Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhen Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhen Mo more than expected).
Fields of papers citing papers by Fengzhen Mo
This network shows the impact of papers produced by Fengzhen Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhen Mo. The network helps show where Fengzhen Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhen Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 80 | |
| 2 | 2021 | 54 | |
| 3 | 2018 | 38 | |
| 4 | 2020 | 36 | |
| 5 | 2021 | 33 | |
| 6 | 2017 | 32 | |
| 7 | 2018 | 31 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 22 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 16 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2018 | 15 | |
| 16 | 2020 | 14 | |
| 17 | 2024 | 11 | |
| 18 | 2021 | 8 | |
| 19 | 2019 | 7 | |
| 20 | 2020 | 2 |
About Fengzhen Mo
Fengzhen Mo is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 22 papers that have together received 490 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Nanowire Synthesis and Applications (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (223 citations), Oncology (228 citations), Radiology, Nuclear Medicine and Imaging (116 citations), Biomaterials (50 citations) and Molecular Biology (217 citations). Fengzhen Mo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoling Lü, Xiaoqiong Hou, Zhuoran Tang, Xiaomei Yang, Aiqun Liu, Siliang Duan, Shihua Yin, Zixi Hu, Xiaomei Yang and Shenxia Xie. Their work appears in journals such as Journal of Biomedical Nanotechnology, Theranostics, International Journal of Nanomedicine, Journal of Nanoscience and Nanotechnology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.